藥物成份

共有 21677 個藥物成份

Standard A-D (4 x 2 mL)\n1; 10; 30; 125 U/mL.\nStandard A=Negative Control Standard B=Cut-Off Control\nStandard C=Weakly Positive Control Standard D=Positive Control\nContains IgM antibodies against Mumps, PBS, stabilizers.\nEnzyme Conjugate IgM (1 x 14 mL)\nContains anti-human IgM, conjugated to peroxidase, protein-containing buffer, stabilizers.\nMicrotiter Plate (1 x 12 x 8)\nBreak apart strips. Coated with specific antigen.\nTMB Substrate Solution (1 x 14 mL)\nContains TMB.\nTMB Stop Solution (1 x 14 mL)\n0.5 M H2SO4.\nDiluent Buffer (1 x 60 mL)\nContains PBS Buffer, BSA, <0.1% NaN3.\nWash Buffer, Concentrate (10X; 1 x 60 mL)\nContains PBS, Buffer, Tween 20.\nAdhesive Foil (2X)\nPlastic Bag (1X)\nResealable.\n

• 關聯藥證數量: 1

Standard A-D: 4 x 2 mL(1;10;35;200 U/mL)Standard A= Negative Control Standard B= Cut-Off ControlStandard C= Weakly Positive Control Standard D= Positive ControlContains IgA antibodies against EBV-EA, PBSEnzyme Conjugate IgA: 1 x 14 mLContains anti-human IgA, conjugated to peroxidase, proteincontaining bufferMicrotiter Plate: 1 x 12 x8Break apart strips. Coated with specific antigen. TMB Substrate Solution: 1 x 14 mLContains TMB.TMB Stop Solution: 1 x 14 mL0.5 M H2SO4.Diluent Buffer: 1 x 60 mL Contains PBS Buffer, BSA,<0.1% NaN3.Wash Buffer, Concentrate (10x): 1 x 60 mLContains PBS Buffer, Tween 20.

• 關聯藥證數量: 1

Standard A-D:\nSaandard A=Negative Control Standard B=Cut-Off Control Standard C=Weakly Positive Control Standard D=Positive Control Contains IgA antibodies against EBV-VCA, PBS, stabilizers.\nEnzyme Conjugate IgA:\nContains anti-human IgA, conjugated to peroxidase, proteincontaining buffer, stabilizers.\nMicrotiter Plate:\nBreak apart strips. Coated with specific antigen.\nTMB Substrate Solution:\nContains TMB.\nTMB Stop Solution:\n0.5 M H2SO4. \nDiluent Buffer:\nContains PBS Buffer, BSA, <0.1% NaN3. \nWash Buffer, Concentrate (10x):\nContains PBS Buffer, Tween 20. \nAdhesive Foil:\nFor covering of Microtiter Plate during incubation.\nPlastic Bag:\nFor dry storage of non-used strips.

• 關聯藥證數量: 1

Standard A-D:\nStandard A = Negative Control\nStandard B = Cut-Off Control\nStandard C = Weakly Positive Control\nStandard D = Positive Control\nContains IgM antibodies against EBV-EA, PBS, stabilizers.\nEnzyme Conjugate IgM:\nContains anti-human IgM, conjugated to peroxidase, proteincontaining buffer.\nMicrotiter Plate\nTMB Substrate Solution:\nContains TMB\nTMB Stop Solution:\n0.5 M H2SO4\nDiluent Buffer:\nContains PBS Buffer, BSA, <0.1% NaN3.\nWash Buffer,\nContains PBS Buffer, Tween 20.

• 關聯藥證數量: 1

Standard A-D\nEnzyme Conjugate IgG\nMicrotiter Plate\nTMB Substrate Solution\nTMB Stop Solution\nDiluent Buffer\nWash Buffer\nAdhesive Foil\nPlastic Bag

• 關聯藥證數量: 1

Standard A-D\nEnzyme Conjugate IgM\nMicrotiter Plate\nTMB Substrate Solution\nTMB Stop Solution\nDiluent Buffer\nWash Buffer\nAdhesive Foil\nPlastic Bag

• 關聯藥證數量: 1

Standard A-D\nStandard A = Negative Control\nStandard B = Cut-Off Control\nStandard C = Weakly Positive Control\nStandard D = Positive Control\nContains IgM antibodies against Mycoplasma, PBS, stabilizers.

• 關聯藥證數量: 1

Standard A-D：\nStandard A = Negative Control\nStandard B = Cut-Off Control\nStandard C = Weakly Positive Control\nStandard D = Positive Control\nContains IgG antibodies against EBV-EA, PBS, stabilizers.\nEnzyme Conjugate IgG：\nContains anti-human IgG, conjuated to peroxidase, proteincontaining buffer, stabilizers.\nMicrotiter Plate：\nBreak apart strips. Coated with specific antigen.\nTMB Substrate Solution：\n0.5 M H2SO4.\nDiluent Buffer：\nContains PBS Buffer, BSA, ＜0.1% NaN3.\nWash Buffer,Concentrate (10X)：1 x 60 mL\nContains PBS Buffer, Tween 20.\nAdhesive Foil：\nFor covering of Microtiter Plate during incubation.\nPlastic Bag：\nFor dry storage of non-used strips.

• 關聯藥證數量: 1

Standards.\nInhibin A Controls:\nOne set of Controls, 1.0 mL each, Levels I and II, containing low and high concentrations of Dimeric Inhibin A in fetal bovine serum with a non-mercury preservative. \n*DSL-10-28100 (4-plate) contains two (2) sets of Controls.\n\nE. Inhibin A Sample Buffer A:\nOne bottle, 10 mL, containing a protein-based buffer with a non-mercury preservative. Store at 2-8°C until\nexpiration date.\n*DSL-10-28100-4 contains one (1)-30 mL bottle.\nF. Inhibin A Sample Buffer B:\nOne bottle, 10 mL, containing a protein-based buffer with a non-mercury preservative. Store at 2-8°C until\nexpiration date.\n*DSL-10-28100 (4-plate) contains one (1)-30 mL bottle.\nG. Inhibin A Antibody-Enzyme Conjugate Concentrate:\nOne vial, containing 0.6 mL of a solution of anti-Inhibin α-subunit antibody conjugated to horseradish\nperoxidase in a protein-based buffer with a non-mercury preservative. Dilute prior to use in Conjugate\nDiluent. Store at 2-8°C until expiration date.\n*DSL-10-28100 (4-plate) contains f

• 關聯藥證數量: 1

Staph Test Latex Reagent:latex particles coated with IgG and human fibrinogen. The latex particles are suspended in buffer containing 0.1% sodium azide as preservative.\nNegative Control Latex Reagent:unsensitized latex particles suspended in buffer containing 0.1% sodium azide as preservative.\n

• 關聯藥證數量: 1

Starch

• 關聯藥證數量: 1

Stem-Kit Reagents contain the following:？ CD45-FITC/CD34-PE Reagent (45/34)-1 vial.？ CD45-FITC/IsoClonic Control-PE Reagent (45/CTRL)-1 vial.？ Stem-Count Fluorospheres-1 vial.？ 7-AAD Viability Dye-1 vial.？ 10X NH4Cl Lysing Solution-2 vials.

• 關聯藥證數量: 1

Stem-Trol Control cells is suspended in an isotonic solution, containing stabilizers and BSA.

• 關聯藥證數量: 1

Sterile Cefoperazone Sodium with Sulbactam Sodium contains NLT 435ug of Cefoperazone (C25H27N9O8S2) and NLT 455ug of Sulbactam (C8H11NO5S) per mg, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Sterile Cephalexin Sodium contains not less than 96.0% and not more than 102.0% of C16H16N3NaO4S calculated on the anhydrous basis.

• 關聯藥證數量: 1

Stop Solution─1 N sulfuric acid.

• 關聯藥證數量: 1

Stopping reagent: 6 mL, hydrochloric and sulfuric acid (<3%).\npositive control: 1 mL, human positive control serum that contains antibodies to Sm, RNP, SSA/Ro, SSB/La, Scl-70, and Jo-1 antigens. contains 0.1% sodium azide as a preservative.\nnegative control: 1 mL, human negaitive control serum that does not contain antibodies to Sm, RNP, SSA/Ro, SSB/La, Scl-70, and Jo-1 antigens. contains 0.1% sodium azide azide as a preservative.

• 關聯藥證數量: 1

Stopping solution (ready for use) :\n1.5 N sulphuric acid

• 關聯藥證數量: 1

Strep-A-Check-1 one step device 20\nExtraction solution1 (6.5 mL) 1 bottle\nExtraction solution2 (6.5 mL) 1 bottle\nSwab 20\n

• 關聯藥證數量: 1

Strepokinase Reagent\n4x2 ml, Each vial contains freeze-dried Streptokinase.\nPlasmin Substrate\n4x2 ml, Each vial contains freeze-dried D-But-CHT-LyspNA.2AcOH.\nDilution Buffer (10X Concentrate)\n4x5 ml with a concentration of 0.975% Sodium Azide as a preservative. Each vial contains Tris-buffered saline which, when fully diluted, optimizes the hydrolysis of the chromogenic substate by the Plasminogen-Streptokinase complex.

• 關聯藥證數量: 1

Streptavidin Coated Tubes\nAnti-TSH Bridge Tracer: containing Biotin labeled and I-125 labelled mouse monoclonal antibodies to TSH, <925 kBq per vial.\nTSH Bridge Calibrators: Zero calibrator containing bovine serum wih sodium azide 0.09% w/v.\nTSH Standards, 2.0 ml per vial, precalibrated to 0.15-0.5-1.5-15-50-150 uIU/ml of TSH per ml in bovine serum\nCoatd Tubes Wash Concentrate: contains an aqueous solution of Triton x-100TM.\nSerotest TSH Control Serum: contains lyophilized human serum.

• 關聯藥證數量: 1

Streptokinase Reagent: contains streptokinase as well as phosphate buffer 50 mmol/l and polygeline as a stabilizer.\nPreservative: sodium azide <1 g/l\nPlasmin Substrate: HD-Norvalyl-cyclohexylalanyl-lysyl-p-nitroanilide (HD-Nva-CHA-lys-pNA); concentration in the working solution: 3 mmol/l.\n

• 關聯藥證數量: 1

Streptomycin Sulfate has a potency is not less than 720 IU/mg, Calculated with reference to the dried substance.

• 關聯藥證數量: 1

Strip Contains:\nGlucose Oxidase (Aspergillus niger) 2 IU\nPotassium ferricyanide 1.5 mg\nNon-reactive ingredient 2.5 mg\nStabilizer 3.5 mg

• 關聯藥證數量: 1

Strip contains：Glucose Oxidase (Aspergillus niger) 2 IU, Potassium ferricyanide 1.5mg, Non-reactive ingredient 2.5mg, Stabilizer 3.5mg

• 關聯藥證數量: 1

Strip contains：\nGlucose Oxidase (Aspergillus niger) 2 IU\nPotassium ferricyanide 1.5 mg\nNon-reactive ingredient 2.5 mg\nStabilizer 3.5 mg

• 關聯藥證數量: 1

Strip: Glucose Oxidase (Aspergillus niger)≧0.7IU, Potassium ferricyanide≧0.02mg, Non-reactive ingredients≧0.12mg\n。Control solution: 2.5(w/w)% D-glucose, 97.5 (w/W)% Non-reactive ingredients。

• 關聯藥證數量: 1

Strip: Glucose Dehydrogenase with Flavin-Adenine Dinucleotide (GDH-FAD)≧1 IU, Non-reactive ingredients≧0.3 mg

• 關聯藥證數量: 1

Strip: Glucose oxidase (A. niger) 13%, Electron shuttle 39%, Enzyme protector 6%, Non-reactive ingredients 42% \nControl Solution: D-glucose 0.03%-0.30%, Inert ingredients >99.7%\n

• 關聯藥證數量: 1

Strip: Glucose oxidase (Aspergillus niger) &#8805; 5.0%, electron shuttle 30%, enzyme stabilizer 5%, other ingredients 60%.\nControl Solution: 0.11% D-Glucose, Sodium benzoate 0.2%, EDTA 0.1%, Red dye 0.2%, Polymer 8.0%.

• 關聯藥證數量: 1

Strip: Glucose oxidase 10%, Electron shuttle 50%, Enzyme protector 8%, Non-reactive ingredients 32%\nControl solution: D-glucose 0.03-0.30%, Inert ingredient >99.7%

• 關聯藥證數量: 1

Strip: Glucose oxidase 10%、Electron shuttle 50%、Enzyme protector 8%、Non-reactive ingredients 32%\nControl solution: D-glucose 0.03-0.30%、Inert ingredient 99.7%以上

• 關聯藥證數量: 1

Strip: Glucose oxidase≧1.2 IU, Non-reactive ingredients≧0.3 mg

• 關聯藥證數量: 1

Strip:Glucose Oxidase (A.niger)13%, Electron Shuttle 39%, Enzyme protector 6%, Non-reactive ingredients 42%, \nControl Solution:D-glucose 0.03%-0.30%, Inert ingredients>99.7%

• 關聯藥證數量: 1

Strip:Glucose Oxidase (Aspergillus niger)≧0.71U, Potassium ferricyanide≧0.02mg, Non-reactive ingredients≧0.12mg\nControl solution: 2.5 (w/w)% D-glucose, 97.5 (w/W)% Non-reactive ingredients

• 關聯藥證數量: 1

Strips: Glucose Oxidase 20 IU, Potassium ferricynide 0.12 mg, Non-reactive ingredients 1.8 mg

• 關聯藥證數量: 1

Strips: Glucose oxidase 10%、Electron shuttle 50%、Enzyme protector 8%、Non-reactive ingredients 32%.\nControl solution: D-glucose 0.03-0.30%、Inert ingredient>99.7%.\n

• 關聯藥證數量: 1

Strips: Glucose oxidase 10%、Electron shuttle 50%、Enzyme protector 8%、Non-reactive ingredients 32%\nControl: D-glucose 0.03-0.30% Inert ingredient>99.7%。\n

• 關聯藥證數量: 1

Strips: Glucose oxidase 10%、Electron shuttle 50%、Enzyme protector 8%、Non-reactive ingredients 32%\nControl: D-glucose 0.03-0.30%、Inert ingredient >99.7%。

• 關聯藥證數量: 1

Strips: Glucose oxidase 10%、Electron shuttle 50%、Enzyme protector 8%、Non-reactive ingredients 32%，Control: D-glucose 0.03-0.30%、 Inert ingredient>99.7%。

• 關聯藥證數量: 1

Strips：Glucose oxidase： 14 Units\n Mediator (Potassium Ferricyanide)： 690 ug\n Buffer： 37 ug\n Stabilizer： 337ug\n Binder：1.4 ug

• 關聯藥證數量: 1

Strip：(GOD) Glucose Oxidase (Aspergillus Niger)：8%, Potassium ferricyanide：56.6%, Non-reactive ingredients：35.4%

• 關聯藥證數量: 1

Strip：Glucose oxidase 10%、Electron shuttle 50%、Enzyme protector 8%、Non-reactive ingredients 32%\nControl：D-Glucose 0.03-0.30%、Inert ingredient > 99.7%

• 關聯藥證數量: 1

Strong Cetrimide Solution(BP) is an aqueous solution of cetrimide. It contains not less than 38.0% w/v and not more than 42.0% w/v (95.0% to 105.0% of 40% w/v solution) of cerimide, calculated as C17H38BrN. It contains Ethanol (96 per cent) or Isoptopyl Alcohol or both. It may be perfumed and may contain colouring matter.

• 關聯藥證數量: 1

Substance Low High\nBovine Serum Albumin 0.45g 0.3g\nTobramycin 0.06mg\nGentamicin 0.06mg\n

• 關聯藥證數量: 1

Substrate Reagent(R1):L-lithium lactate 8.23mg/mLCoenzyme Reagent(R2):β-nicotinamide adenine dinucleotide oxidation type (NAD) 15.4mg/mL

• 關聯藥證數量: 1

Substrate Reagent─5-bromo-4-chloro-3-indolyl phosphate and 0.1% sodium azide.

• 關聯藥證數量: 1

Substrate Sildes: Crithidia Iuciliae stabilized directly on the test wells. Positive Control: 1.0ml positive human control serum with antibody specific to nDNA antigens. Titratable Control Serum: 1.0ml positive human control serum. Negative Control Serum: 1.0ml negative human control serum. Fluorescent Antibody Reagent: 9.0ml Goat anti-human IgG (heavy and light chains) conjugated to fluorescein isothiocyanate (FITC). PBS Buffer Powder: Phosphate-buffered saline powder (0.01 M, pH 7.4±0.2).

• 關聯藥證數量: 1

Substrate Slides: Catalog No. 2007 (seven-well); 2013\n(thirteen-well): HEp-2 cells (with mitotic figures) grown and stabilized directly on the test wells. \n\nCatalog No. 2007-Ro (seven-well);\n2013-Ro (thirteen-well): HEp-2000R cells (with mitotic\nfigures) grown and stabilized directly on the test wells.\nThese are HEp-2 cells that have been stably transfected\nwith the SSA/Ro autoantigen. \n\nSSA/Ro Positive Control(Hep-2000 ANA Test Kit only)\n: Catalog No. 2035-Ro. Ready-to-use dropper vial containing \n1.0 ml positive human control serum with antibody specific to SSA/Ro antigens.\n\n

• 關聯藥證數量: 1

Substrate Slides: each slide well contains fixed Crithidia luciliae hemoflagellates.\nFluorescent Antibody Conjugate: Goat antihuman immunoglobulin conjugated with fluorescein isothiocyanate (FITC). ProClinTM 300, 0.05% w/v, is added as a preservative. Evans Blue is added as a counterstain.\nnDNA Positive Control Serum: Human serum in dropper vial containing anti-native DNA antibodies. Sodium azide, 0.1% w/v, is added as a preservative.\nAutoantibody Negative Control Serum: Human serum in dropper vial containing no detectable autoantibodies. Sodium azide, 0.1% w/v, is added as a preservative.\nPBS: Contains dry granular phosphate buffered saline blend.\nMounting Medium: Contains phosphate buffered glycerol with 0.05% w/v ProClinTM 300 added as a preservative.\n

• 關聯藥證數量: 1

Substrate Slides:Each HEp-2 well slide contains HEp-2 cell grown and fixed on the slide.Fluorescent Antibody Conjugate:Goat or rabbit (see vial label) anti-human immunoglobulin conjugated with fluroescein isothiocyanate (FITC). Evans Blue is added as a counterstain.ANA (Homogeneous) Positive Control Serum:Ready to use human serum in dropper vial containing antinuclear antibodies demonstrating a strong homogeneous staining reaction on HEp-2 cells.ANA (Homogeneous) Endopint Reference Control Serum:Ready to use human serum in dropper vial containing antinuclear antibodies demonstrating a minimal homogeneous staining reaction on HEp-2 cells.Autoantibody Negative Control Serum:Ready to use human serum in dropper vial containing no detectable autoantibodies. Sodium azide 0.1% is added as a presercative.PBS:Contains dry granular phosphate buffered saline blend.Mounting Medium:Ready to use dropper vial. Contains phosphate buffered glycerolBlotting Strips

• 關聯藥證數量: 1

Substrate-Enzyme：\n25 mmol/L Tris buffer,pH9.0\n200 mmol/L L-Alanine\n0.31 mmol/L NADH(yeast)\n12800 IU/L (37℃)LDH (microorganism)\nα-KG：\n260 mmol/L Tris buffer,pH4.8\n1150 mmol/L L-Alanine\n46.5 mmol/L α-Ketoglutarate

• 關聯藥證數量: 1

Substrate: Glucose, Sucrose, Sorbitol, Raffinose, Rhamnose, Arabinose, Inositol, Adonitol, Melibiose, Urea, Hydrogen Sulfide, Indole, Lysine, Arginine, Ornithine, Tryptophan Deaminase, Esculin, Voges-Proskauer, Citrate, Malonate, o-Nitrophenyl-β-D-Galactopyranoside, Tartrate, Acetamide, Cetrimide, OF Glucose, OF Base, Decarboxylase Base, Nitrate, Kanamycin, Colistin, Penicillin, Nitrofurantoin, Cephalothin, Tobramycin\nAntimicrobial: Amikacin, Amoxicillin/K Clavulanate, Ampicillin, Ampicillin/Sulbactam, Aztreonam, Cefazolin, Cefepime, Cefotaxime, Cefotaxime/K Clavulanate, Cefotetan, Cefoxitin, Ceftazidime, Ceftazidime/K Clavulanate, Ceftriaxone, Cefuroxime, Cephalothin, Ciprofloxacin, Ertapenem, Gentamicin, Imipenem, Levofloxacin, Meropenem, Moxifloxacin, Nitrofurantoin, Piperacillin/Tazobactam, Tetracydine, Ticarcillin/K Clavulanate, Tobramycin, Trimethoprim/Sulfamethoxazole

• 關聯藥證數量: 1

Substrate: Glucose-6-P 1mmol/l、\n NADP 0.75mmol/l、\n GGSG (oxidized glutathione) 0.8mmol/l、\nBuffer: Saponin 0.2%、\n Tris (hydroxymethyl)、\n Aminomethane 225mmol/l; pH7.8

• 關聯藥證數量: 1

Substrate:\nTris buffer 71.5 mmol/l, pH 8.25\nGlycylglycine 126 mmol/l\nL-r-glutamyl-p-nitroanilide 4 mmol/l\nSurfactants

• 關聯藥證數量: 1

Substrate：2-(Ethylamino) ethanol (EAE) buffer, pH9.9；4-Nitrophenylphosphate, disodium salt (4NPP)

• 關聯藥證數量: 1

Subtilisin A.....2.0mg\nSodium Chloride.....30.5mg\nTartaric acid.....17.2mg\nSodium Carbonate.....21.8mg\nSodium bicarbonate.....22.2mg\nPolyethyleneglycol 6000.....2.3mg\n以下空白

• 關聯藥證數量: 1

Succinate buffer 90 mmol/L\nBromocresol Green 0.26 mmol/L

• 關聯藥證數量: 1

Succinate buffer (pH 4.2) 100 mmol/l;\nBromocresol green 0.2 mmol/l;\nPreservative

• 關聯藥證數量: 1

Succinate buffer (pH4.2+-0.2) 75 mmol/L\nBromcresol green 0.15 mmol/L

• 關聯藥證數量: 1

Succinic Acid and 0.05% NaNO3

• 關聯藥證數量: 1

Succinylcholine Chloride contains not less than 96.0% and not more than 102.0% of C14H30Cl2N2O4, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Sucralfate Humid Gel equivalent to Sucralfate

• 關聯藥證數量: 1

Sucralfate contains the equivalent of not less than 30% and not more than 38% of C12H14O35S8.

• 關聯藥證數量: 1

Sucralfate contains： - sucrose octasulfate (C12H14O35S88-)：30.0% to 36.0% - aluminium (Al)：16.5% to 18.5%

• 關聯藥證數量: 1

Sucralfate is the hydrous basic aluminum salt of sucrose octasulfate It contains the equivalent of not less than 30.0 percent and not more than 38.0 percent of sucrose octasulfate (C12H14O35S8).

• 關聯藥證數量: 1

Sucralfate is the hydrous basic aluminum salt of sucrose octasulfate. It contains the equivalent of not less than 30.0 percent and not more than 38.0 percent of sucrose octasulfate (C12H14O35S8)

• 關聯藥證數量: 1

Sucralfate is the hydrous basis aluminum salt of sucrose octasulfate. It contains the equivalent of not less than 30.0 percent and not more than 38.0 percent of sucrose octasulfate (C12H14O35S8).

• 關聯藥證數量: 1

Sugammadex Sodium contains not less than 95.0% and not more than 102.0% of C72H104Na8O48S8, calculated on anhydrous and solvent free basis.

• 關聯藥證數量: 1

Sugammadex contains not less than 89% and not more than 102% of C72H104O48S8Na8, and Sodium contains not less than 7% and not more than 9% of C72H104O48S8Na8 calculate on no anhydrous and no ethanol basis.

• 關聯藥證數量: 1

Sugammadex sodium contains not less than 96.0% and not more than 102.0% of C72H104O48S8Na8, calculated on the anhydrous substance.

• 關聯藥證數量: 1

Sulbactam Sodium contains NLT 88.6% and NMT 94.1% of sulbactam (C8H11NO5S), calculated on the anhydrous basis.

• 關聯藥證數量: 1

Sulbactam Sodium contains not less than 886ug and not more than 941ug of Sulbactam (C8H11NO5S) per mg (on the anhydrous basis)

• 關聯藥證數量: 1

Sulfadiazine Silver contains not less than 98.0% and not more than 102.0% of C10H9AgN4O2S, calculated on the dried basis.

• 關聯藥證數量: 1

Sulfadiazine contains not less than 99.0 % and not more than the equivalent of 101.0 % of 4-amino-N-pyrimidin-2-ylbenzenesulphonamide, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Sulfadiazine contains not less than 99.0% and not more than the equivalent of 101.0% of 4-amino-N-pyrimidin-2-ylbenzensulphonamide,calculated with reference to the dried substance.

• 關聯藥證數量: 1

Sulfadimidine contains not less than 99.0% and not more than the equivalent of 101.0% of C12H14N4O2S, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Sulfamethazine contains not less than 99.0% and not more than 100.5% of C12H14N4O2S, calculated on the dried basis.

• 關聯藥證數量: 1

Sulfamethoxazole Sodium Assay:98.0~100.5%

• 關聯藥證數量: 1

Sulfamethoxazole Sodium contains not less than 98.0% and not more than 100.5% of C10H10N3O3S, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Sulfamethoxazole Sodium contains not less than 99.0% and not more than 100.5% of C10H10N3NaO3S (dried substance).

• 關聯藥證數量: 1

Sulfamethoxazole contains not less than 99.0% not more than the equivalent of 101.0% of C10H11N3O3S, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Sulfamine

• 關聯藥證數量: 1

Sulfanilic acid：27 mmol/L HCL：51 mmol/L Sodium nitrite：0.12 mmol/L

• 關聯藥證數量: 1

Sulfasalazine contains not less than 97.0% and not more than 101.5% of C18H14N4O5S, calculated on the dried basis.

• 關聯藥證數量: 1

Sulfasalazine contains not less than 97.0% and not more than 101.5% of C18H14N4O5S, calculated on the dried substance.

• 關聯藥證數量: 1

Sulfuric acid 10 mmol/L\nAmmonium molybdate 3.4 mmol/L

• 關聯藥證數量: 1

Sulindac contains 99.0%~101.0% of C20H17FO3S, calculated on the dried basis.

• 關聯藥證數量: 1

Sulindac contains not less than 99.0 percent and not more than 101.0 percent of C20H17FO3S, calculated on the dried basis.

• 關聯藥證數量: 1

Sulindac contains not less than 99.0% and not more than 101.0% of C20H17FO3S, calcluated on the dried basis.

• 關聯藥證數量: 1

Sulindac contains not less than 99.0% and not more than 101.0% of C20H17FO3S, calculated on the dried basis.

• 關聯藥證數量: 1

Sulindac contains not less than 99.0% and not more than the equivalent of 101.0% of C20H17FO3S,calculated with reference to the dried substance.

• 關聯藥證數量: 1

Sulindac contains not less then 99.0% and not more then 101.0% of C20H17FO3S, Calculated on the dried basis

• 關聯藥證數量: 1

Sulphamethoxazole contains not less than 99.0% and not more than 101.0% of C10H11N3O3S, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Sulphamethoxazole contains not less than 99.0% and not more than 101.0% of C10H11N3O3S, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Sulphamethoxazole/Trimethoprim 25ug/disc

• 關聯藥證數量: 1

Sulphanilic acid 29 mmol/l\nSodium Nitrite 0.17 mol/l\nHydrochloric acid 38.5 mmol/l

• 關聯藥證數量: 1

Sulphur hexafluoride microbubbles

• 關聯藥證數量: 1

Sulphuric acid 200 mmol/l\nAmmoniumheptamolybdate 0.35mmol/l\nGlycine 50mmol/l\nPreservative

• 關聯藥證數量: 1

Sulpiride Content: 98.5 percent to 101.0% percent of C15H23N3O4S (dried substance).

• 關聯藥證數量: 1